Hostname: page-component-76fb5796d-wq484 Total loading time: 0 Render date: 2024-04-25T14:45:13.573Z Has data issue: false hasContentIssue false
  • English
  • Français

Clinical Research upon Mentally Ill Subjects Who Cannot Give Informed Consent

Published online by Cambridge University Press:  29 January 2018

I. G. Pryce
I. G. Pryce*
Affiliation:
Whitchurch Hospital, Cardiff
Get access Rights & Permissions [Opens in a new window]

Extract

The Problem

Over the last two decades increasing attention has been paid to the rights and safety of the subjects of clinical research. A key safeguard against any abuse has been the requirement to obtain the subject's informed, valid or true consent, which has been defined by the Medical Research Council as ‘consent freely given with proper understanding of the nature and consequences of what is proposed’ (M.R.C., 1962–3). However, it has been recognized by the M.R.C. that it may not be possible to obtain such consent from, among others, some subjects who are mentally ill. Whether or not a research project should be carried out on such subjects should depend, they say, on whether or not ‘there are reasonable grounds for believing that a particular new procedure will contribute to the benefit of that particular patient…’, and further, ‘when true consent cannot be obtained, procedures which are of no direct benefit and which might carry a risk of harm to the subject should not be undertaken’ (M.R.C., 1962–3).

Type
Research Article
Information
The British Journal of Psychiatry , Volume 133 , Issue 4 , October 1978 , pp. 366 - 369
Copyright
Copyright © Royal College of Psychiatrists, 1978 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Beaumont, J. G. & Dimond, S. T. (1973) Brain disconnection and schizophrenia. British Journal of Psychiatry, 123, 661–2.Google Scholar
Buresova, O. & Bures, J. (1976) Piracetam-induced facilitation of interhemispheric transfer of visual information in rats. Psychopharmocologia, Berlin, 45, 93–102.Google Scholar
Gostin, L. O. (1975) A Human Condition, Vol. 1, p. 117. London: MIND (National Association for Mental Health).Google Scholar
Leff, J. P. (1972) Maintenance therapy and schizophrenia. British Journal of Hospital Medicine, 377–80.Google Scholar
Medical Research Council, Report for the Tear 1962–3, Cmnd. 2382, pp 21–25. London: H.M.S.O., 1964.Google Scholar
Pryce, I. G. & Gray, C. (1978) Trial of ‘Piracetam’ in chronic schizophrenia. British Journal of Psychiatry, 132, 205 (letter).Google Scholar
Riis, P. (1977) Planning of scientific-ethical committees. British Medical Journal, ii, 173–4.Google Scholar
Rosenthal, R. & Bigelow, L. B. (1972) Quantitative brain measurements in chronic schizophrenia. British Journal of Psychiatry, 121, 259–64.Google Scholar
The Declaration of Helsinki (1976) World Medical Journal, 76–7.Google Scholar
Wing, J. K. (1961) A simple and reliable sub-classification of chronic schizophrenia. Journal of Mental Science, 107, 862–75.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.